Internal Medicine, Hematology & Oncology · Flint, MI
NPI
1114276474
Since 2012
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
4100 Beecher Rd Ste B
Flint, MI, 48532
Phone (810) 235-8568
Groups this clinician bills Medicare through
Medicare paid, 2024
$95K
1,053 services
Medicare patients, 2024
329
Average age 75
Drug cost, 2024
$4.2M
2,213 prescriptions
Company payments, 2023
$30.98
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Orimisan S Adekolujo was code 99214 (office e&m - established), 342 times for 186 patients. In total Orimisan S Adekolujo billed 1,053 services in 12 codes, and Medicare paid $95K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-09-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 342 | 186 | $70.39 | $24K |
| 99215 Office E&M - Established | Facility | 326 | 96 | $112.28 | $37K |
| 99232 Hospital E&M - Subsequent | Facility | 95 | 57 | $64.32 | $6,111 |
| 99233 Hospital E&M - Subsequent | Facility | 89 | 50 | $94.67 | $8,426 |
| 99223 Hospital E&M - Initial | Facility | 68 | 61 | $139.31 | $9,473 |
| 99213 Office E&M - Established | Facility | 45 | 38 | $41.34 | $1,860 |
| 99205 Office E&M - New | Facility | 36 | 36 | $126.45 | $4,552 |
| 99222 Hospital E&M - Initial | Facility | 30 | 30 | $106.98 | $3,209 |
By year: 2022 $24K for 297 services; 2023 $71K for 866 services; 2024 $95K for 1,053 services.
Medicare prescription drug claims, 2024
In 2024, the drug Orimisan S Adekolujo prescribed most often to Medicare patients was Anastrozole, with 160 prescriptions and refills. In total Orimisan S Adekolujo wrote 2,213 Medicare prescriptions that cost $4.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 160 | 442 | 56 | $10K |
| Eliquis Apixaban | 133 | 184 | 36 | $103K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 131 | 131 | 45 | $2,258 |
| Ondansetron Odt Ondansetron | 88 | 114 | 57 | $7,226 |
| Olanzapine Generic | 78 | 117 | 40 | $953 |
| Pantoprazole Sodium Generic | 68 | 98 | 19 | $328 |
| Tamoxifen Citrate Generic | 57 | 137 | 15 | $2,731 |
| Dexamethasone Generic | 57 | 66 | 36 | $965 |
| Loperamide Loperamide Hcl | 55 | 57 | 44 | $1,282 |
| Prochlorperazine Maleate Generic | 49 | 58 | 39 | $1,283 |
| Levothyroxine Sodium Generic | 45 | 94 | 19 | $1,120 |
| Acyclovir Generic | 44 | 72 | 13 | $794 |
| Prednisone Generic | 43 | 53 | 24 | $253 |
| Ondansetron Hcl Generic | 39 | 44 | 23 | $513 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 39 | 40 | 30 | $377 |
Brand drugs: 452 claims; generic drugs: 1,761 claims; opioid claims: 230.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Orimisan S Adekolujo $30.98 ($30.98 in general payments such as food, travel and fees) from 1 company. The largest payer was Amgen Inc. with $30.98.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 2 | $30.98 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.